Thomas Gad - 21 Dec 2023 Form 4 Insider Report for Y-mAbs Therapeutics, Inc. (YMAB)

Role
Chief Business Officer, Director
Signature
/s/ Thomas Gad
Issuer symbol
YMAB
Transactions as of
21 Dec 2023
Transactions value $
$100,000
Form type
4
Filing time
26 Dec 2023, 16:15:24 UTC
Previous filing
15 Dec 2023
Next filing
22 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction YMAB Common Stock Options Exercise $100K +50K +55.25% $2.00 141K 21 Dec 2023 Direct F1, F2
holding YMAB Common Stock 265K 21 Dec 2023 By GAD Enterprises LLC F3
holding YMAB Common Stock 60K 21 Dec 2023 By Children F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction YMAB Employee Stock Option (right to buy) Options Exercise $0 -50K -32.68% $0.00 103K 21 Dec 2023 Common Stock 50K $2.00 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired through the exercise of Employee Stock Options.
F2 Represents 100,000 shares of Common Stock owned by Reporting Person as well as 40,500 restricted stock units ("RSUs") granted to the Reporting Person on January 17, 2023 pursuant to the 2018 Equity Incentive Plan of Y-mAbs Therapeutics, Inc. Each RSU represents a contingent right to receive one share of Common Stock on the vesting dates of the RSU. The RSUs vest by 1/3 on each of January 17, 2024, January 17, 2025 and January 17, 2026 subject to the continuing employment of the Reporting Person on each vesting date.
F3 Reporting Person is sole member of GAD Enterprises, LLC and the sole member and manager of GAD Management, LLC, the manager of GAD Enterprises, LLC, and as such Reporting Person has sole voting and dispositive power with respect to such shares.
F4 Represents shares owned by Reporting Person's children who are deemed to share Reporting Person's household.
F5 The stock option vested and became exercisable as to 25% of the shares subject to the option on June 10, 2016, and thereafter vested as to 1/48th of the shares in equal monthly installments, until such time as the option was 100% vested on June 10, 2019.